Clinical Trials & REMS in the Time of Corona: FDA & MHRA Advice and Guidance

/ Apr 09, 2020

Pharmacovigilance expert Bart Cobert discusses the FDA and MHRA guidance for non-Corona related clinical trials.

Read More

Does Rapid FDA Approval Produce Drug Safety Issues?

/ Mar 16, 2020

Bart Cobert gives his pharmacovigilance point of view on a recent paper on FDA approval timelines and drug safety issues.

Read More

Clintrials.gov Update

/ Feb 11, 2020

Bart Cobert on the importance of publishing clinical trials data and implications on pharmacovigilance.

Read More

Pharmacovigilance 2030

/ Dec 11, 2019

This is an interesting article looking at what PV will be in the year 2030.

Read More

FDA Draft Guidance on PMRs

/ Nov 24, 2019

Bart Cobert highlights the most important changes in the recently revised FDA draft guidance on PMRs.

Read More

Ranitidine – What Happened and What Do We Learn?

/ Oct 31, 2019

Bart Cobert explores several important points to take from the still ongoing signal and safety issue with Renitidine recall.

Read More

Video Email: Your Secret Weapon in Improving cSat

/ Oct 23, 2019

The advantages of utilizing video email response to overcome low customer satisfaction.

Read More

Why Coupons Are Still a Powerful Strategy for Brands

/ Oct 14, 2019

When it comes to driving consumer behavior, coupons continue to be a powerful force.

Read More

Going Mobile: Creating Experiences that Matter with the Avaya Mobile Experience

/ Oct 14, 2019

Read how C3i Solutions is leveraging Avaya Mobile Experience to provide better customer experience.

Read More

Vaping – A Serious Safety Signal

/ Oct 07, 2019

Bart Cobert discusses the major safety issue in the US on e-cigarettes and vaping.

Read More

Blog Signup